The 5-Hydroxytryptamine 4 Receptor Agonists Prucalopride and PRX-03140 Increase Acetylcholine and Histamine Levels in the Rat Prefrontal Cortex and the Power of Stimulated Hippocampal θ Oscillations

Saved in:
Bibliographic Details
Published inThe Journal of pharmacology and experimental therapeutics Vol. 341; no. 3; pp. 681 - 691
Main Authors Johnson, David E., Drummond, Elena, Grimwood, Sarah, Sawant-Basak, Aarti, Miller, Emily, Tseng, Elaine, McDowell, Laura L., Vanase-Frawley, Michelle A., Fisher, Katherine E., Rubitski, David M., Stutzman-Engwall, Kim J., Nelson, Robin T., Horner, Weldon E., Gorczyca, Roxanne R., Hajos, Mihaly, Siok, Chester J.
Format Journal Article
LanguageEnglish
Published 01.06.2012
Online AccessGet full text

Cover

Author Hajos, Mihaly
Fisher, Katherine E.
Siok, Chester J.
Johnson, David E.
Drummond, Elena
Vanase-Frawley, Michelle A.
Rubitski, David M.
Stutzman-Engwall, Kim J.
Grimwood, Sarah
Tseng, Elaine
Nelson, Robin T.
Miller, Emily
McDowell, Laura L.
Horner, Weldon E.
Gorczyca, Roxanne R.
Sawant-Basak, Aarti
Author_xml – sequence: 1
  givenname: David E.
  surname: Johnson
  fullname: Johnson, David E.
– sequence: 2
  givenname: Elena
  surname: Drummond
  fullname: Drummond, Elena
– sequence: 3
  givenname: Sarah
  surname: Grimwood
  fullname: Grimwood, Sarah
– sequence: 4
  givenname: Aarti
  surname: Sawant-Basak
  fullname: Sawant-Basak, Aarti
– sequence: 5
  givenname: Emily
  surname: Miller
  fullname: Miller, Emily
– sequence: 6
  givenname: Elaine
  surname: Tseng
  fullname: Tseng, Elaine
– sequence: 7
  givenname: Laura L.
  surname: McDowell
  fullname: McDowell, Laura L.
– sequence: 8
  givenname: Michelle A.
  surname: Vanase-Frawley
  fullname: Vanase-Frawley, Michelle A.
– sequence: 9
  givenname: Katherine E.
  surname: Fisher
  fullname: Fisher, Katherine E.
– sequence: 10
  givenname: David M.
  surname: Rubitski
  fullname: Rubitski, David M.
– sequence: 11
  givenname: Kim J.
  surname: Stutzman-Engwall
  fullname: Stutzman-Engwall, Kim J.
– sequence: 12
  givenname: Robin T.
  surname: Nelson
  fullname: Nelson, Robin T.
– sequence: 13
  givenname: Weldon E.
  surname: Horner
  fullname: Horner, Weldon E.
– sequence: 14
  givenname: Roxanne R.
  surname: Gorczyca
  fullname: Gorczyca, Roxanne R.
– sequence: 15
  givenname: Mihaly
  surname: Hajos
  fullname: Hajos, Mihaly
– sequence: 16
  givenname: Chester J.
  surname: Siok
  fullname: Siok, Chester J.
BookMark eNotkU1OwzAQhS0EEm1hzdYXCHgS2y3LqgJaqVKrUiR2keNMaKrUjmwXyM24ATvOhENZzdP8fDOaNyTnxhok5AbYLUDK7_Ythl7dwn2aCTgjAxApJAxYdk4GjKVpkgkpLsnQ-z1jwLnMBuR7u0MqknlXOvvZBde1QR1qg5TTDWpsg3V0-mZN7YOna3fUqrGtq0ukypR0vXlNWAac0YXRDpVHOtUYukbvbNNT-qZ5nD0xl_iOjae1oSFu3agQiVg5a4Jq6My6gJ9_E311bT_QUVvR51Afjo0K2JPa1mp1aGP7zxddeV03sVJb46_IRaUaj9f_cUReHh-2s3myXD0tZtNlokHIkKRjLFPOtYSJKGKmkvF12URJAEDBxoorwbmQrKxKLbRQrJSpKHgBY1kW9yIbkbsTVzvrfbw-j984KNflwPLeh7z3oVf5yYfsF8wigUU
CitedBy_id crossref_primary_10_1111_jphp_12030
crossref_primary_10_1017_S0033291719002836
crossref_primary_10_1016_j_pharmthera_2014_07_001
crossref_primary_10_1016_j_neuropharm_2017_08_031
crossref_primary_10_1021_acs_jmedchem_8b00457
crossref_primary_10_1242_jcs_249193
crossref_primary_10_1007_s00429_014_0864_z
crossref_primary_10_1016_j_cellsig_2012_05_008
crossref_primary_10_1186_s12883_018_1083_7
crossref_primary_10_1002_hipo_22244
crossref_primary_10_1097_FBP_0000000000000296
crossref_primary_10_3389_fncel_2024_1338502
crossref_primary_10_1080_17460441_2019_1546691
crossref_primary_10_1017_S0033291720000604
crossref_primary_10_1111_bph_12397
crossref_primary_10_1021_acsomega_1c00341
crossref_primary_10_3389_fpsyt_2022_859123
crossref_primary_10_1021_acs_jmedchem_1c00703
crossref_primary_10_1016_j_neulet_2016_01_055
crossref_primary_10_29254_2077_4214_2021_4_162_40_46
crossref_primary_10_3390_ijerph16173137
crossref_primary_10_1021_cn500340j
crossref_primary_10_1016_j_ejmech_2014_05_015
crossref_primary_10_1016_j_neurobiolaging_2013_01_020
crossref_primary_10_3389_fnbeh_2020_620119
crossref_primary_10_1016_j_ejphar_2016_07_024
crossref_primary_10_1016_j_expneurol_2021_113743
crossref_primary_10_1016_j_neuropharm_2016_03_043
crossref_primary_10_1021_jm300953p
crossref_primary_10_3109_00498254_2016_1152522
crossref_primary_10_1017_S1092852915000358
crossref_primary_10_1016_j_bcp_2015_06_031
crossref_primary_10_1016_j_bpsc_2023_03_014
crossref_primary_10_1038_s41398_021_01568_4
crossref_primary_10_1016_j_ejphar_2023_175625
crossref_primary_10_1016_S0013_7006_16_30015_X
crossref_primary_10_1080_13543776_2020_1767587
crossref_primary_10_29254_2077_4214_2023_4_171_42_47
crossref_primary_10_1016_j_neuropharm_2014_05_013
crossref_primary_10_1016_j_pnpbp_2016_03_001
crossref_primary_10_1111_bdi_13245
crossref_primary_10_1007_s10151_013_1106_8
Cites_doi 10.1126/science.7046051
10.1111/j.1476-5381.1990.tb12701.x
10.1016/S0169-328X(01)00095-X
10.1016/j.neuropharm.2007.06.016
10.1016/S0304-3940(97)13379-1
10.1007/PL00005110
10.1007/s00210-004-0919-4
10.1002/bdd.325
10.1038/sj.mp.4001763
10.1016/S0014-2999(01)01087-1
10.1016/0028-3908(96)00191-8
10.1097/00001756-199406020-00018
10.1002/(SICI)1098-2396(200004)36:1<35::AID-SYN4>3.0.CO;2-Y
10.1016/j.ejphar.2006.11.048
10.2967/jnumed.108.058552
10.1097/FBP.0b013e3282ee82e3
10.1111/j.1476-5381.1995.tb13303.x
10.1523/JNEUROSCI.3737-05c.2006
10.1046/j.1460-9568.2001.01361.x
10.1046/j.1471-4159.1998.70062252.x
10.1002/j.1460-2075.1995.tb07280.x
10.1016/j.pharmthera.2009.03.002
10.1002/1099-081X(199912)20:9<429::AID-BDD209>3.0.CO;2-D
10.1016/0306-4522(91)90070-5
10.1254/jphs.FP0072230
10.1016/S0028-3908(96)00169-4
10.1046/j.1460-9568.2002.02005.x
10.1101/lm.68004
10.1016/S0166-4328(01)00226-1
10.1016/S0028-3908(97)00055-5
10.1016/S0197-0186(98)00074-6
10.1038/mp.2008.28
10.1007/s002130050529
10.1007/BF02249415
10.1016/S0306-4522(97)00239-X
10.1007/s00210-005-1068-0
10.1016/j.neuropharm.2011.02.026
10.1016/S0165-6147(00)89081-1
10.1016/j.bbr.2007.10.008
10.1111/j.1460-9568.2005.04560.x
10.1007/s00213-003-1683-8
10.1124/jpet.107.130070
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1124/jpet.112.192351
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1521-0103
EndPage 691
ExternalDocumentID 10_1124_jpet_112_192351
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
2WC
3O-
4.4
53G
5GY
5RE
5VS
8WZ
A6W
AAJMC
AAYOK
AAYXX
ABCQX
ABIVO
ABJNI
ABOCM
ABSQV
ACGFO
ACGFS
ACNCT
ADBBV
ADCOW
ADIYS
AENEX
AERNN
AFFNX
AFHIN
AFOSN
AGFXO
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
F9R
FDB
GX1
H13
HZ~
INIJC
KQ8
L7B
LSO
MJL
MVM
O9-
OHT
OK1
P2P
R.V
R0Z
RHF
RHI
RPT
TR2
UQL
VH1
W2D
W8F
WH7
WOQ
X7M
YBU
YHG
YQT
ZGI
ZXP
ID FETCH-LOGICAL-c156t-27ed244c6185b156f612438a6111e507a4a544560dfdc5c5a0d625b4b176db953
ISSN 0022-3565
IngestDate Fri Dec 06 03:33:29 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c156t-27ed244c6185b156f612438a6111e507a4a544560dfdc5c5a0d625b4b176db953
PageCount 11
ParticipantIDs crossref_primary_10_1124_jpet_112_192351
PublicationCentury 2000
PublicationDate 2012-06-00
PublicationDateYYYYMMDD 2012-06-01
PublicationDate_xml – month: 06
  year: 2012
  text: 2012-06-00
PublicationDecade 2010
PublicationTitle The Journal of pharmacology and experimental therapeutics
PublicationYear 2012
References 2019081411491291000_341.3.681.30
Roth (2019081411491291000_341.3.681.40) 2004; 174
2019081411491291000_341.3.681.12
2019081411491291000_341.3.681.11
Kinney (2019081411491291000_341.3.681.28) 1999; 291
2019081411491291000_341.3.681.33
2019081411491291000_341.3.681.10
2019081411491291000_341.3.681.31
2019081411491291000_341.3.681.38
2019081411491291000_341.3.681.15
2019081411491291000_341.3.681.37
2019081411491291000_341.3.681.14
Galeotti (2019081411491291000_341.3.681.20) 1998; 286
2019081411491291000_341.3.681.36
2019081411491291000_341.3.681.35
2019081411491291000_341.3.681.19
2019081411491291000_341.3.681.18
2019081411491291000_341.3.681.17
2019081411491291000_341.3.681.39
Medhurst (2019081411491291000_341.3.681.34) 2001; 90
2019081411491291000_341.3.681.9
Blondel (2019081411491291000_341.3.681.6) 1998; 70
2019081411491291000_341.3.681.8
Dumuis (2019081411491291000_341.3.681.16) 1988; 34
2019081411491291000_341.3.681.41
Boddeke (2019081411491291000_341.3.681.7) 1990; 101
2019081411491291000_341.3.681.23
2019081411491291000_341.3.681.45
2019081411491291000_341.3.681.22
2019081411491291000_341.3.681.44
2019081411491291000_341.3.681.43
2019081411491291000_341.3.681.42
2019081411491291000_341.3.681.3
2019081411491291000_341.3.681.27
2019081411491291000_341.3.681.2
2019081411491291000_341.3.681.26
2019081411491291000_341.3.681.48
2019081411491291000_341.3.681.5
2019081411491291000_341.3.681.25
2019081411491291000_341.3.681.47
2019081411491291000_341.3.681.4
2019081411491291000_341.3.681.24
2019081411491291000_341.3.681.46
2019081411491291000_341.3.681.1
2019081411491291000_341.3.681.29
Matsumoto (2019081411491291000_341.3.681.32) 2001; 296
Gerald (2019081411491291000_341.3.681.21) 1995; 14
Claeysen (2019081411491291000_341.3.681.13) 1999; 55
References_xml – ident: 2019081411491291000_341.3.681.4
  doi: 10.1126/science.7046051
– volume: 291
  start-page: 99
  year: 1999
  ident: 2019081411491291000_341.3.681.28
  article-title: Cognition-enhancing drugs increase stimulated hippocampal θ rhythm amplitude in the urethane-anesthetized rat
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: Kinney
– volume: 101
  start-page: 281
  year: 1990
  ident: 2019081411491291000_341.3.681.7
  article-title: Zacopride and BRL 24924 induce an increase in EEG-energy in rats
  publication-title: Br J Pharmacol
  doi: 10.1111/j.1476-5381.1990.tb12701.x
  contributor:
    fullname: Boddeke
– volume: 90
  start-page: 125
  year: 2001
  ident: 2019081411491291000_341.3.681.34
  article-title: Quantitative mRNA analysis of five C-terminal splice variants of the human 5-HT4 receptor in the central nervous system by TaqMan real time RT-PCR
  publication-title: Mol Brain Res
  doi: 10.1016/S0169-328X(01)00095-X
  contributor:
    fullname: Medhurst
– ident: 2019081411491291000_341.3.681.36
  doi: 10.1016/j.neuropharm.2007.06.016
– ident: 2019081411491291000_341.3.681.42
  doi: 10.1016/S0304-3940(97)13379-1
– ident: 2019081411491291000_341.3.681.48
  doi: 10.1007/PL00005110
– ident: 2019081411491291000_341.3.681.9
  doi: 10.1007/s00210-004-0919-4
– ident: 2019081411491291000_341.3.681.27
  doi: 10.1002/bdd.325
– ident: 2019081411491291000_341.3.681.46
  doi: 10.1038/sj.mp.4001763
– ident: 2019081411491291000_341.3.681.10
  doi: 10.1016/S0014-2999(01)01087-1
– ident: 2019081411491291000_341.3.681.18
  doi: 10.1016/0028-3908(96)00191-8
– ident: 2019081411491291000_341.3.681.14
  doi: 10.1097/00001756-199406020-00018
– ident: 2019081411491291000_341.3.681.8
  doi: 10.1002/(SICI)1098-2396(200004)36:1<35::AID-SYN4>3.0.CO;2-Y
– ident: 2019081411491291000_341.3.681.24
  doi: 10.1016/j.ejphar.2006.11.048
– ident: 2019081411491291000_341.3.681.31
  doi: 10.2967/jnumed.108.058552
– ident: 2019081411491291000_341.3.681.33
  doi: 10.1097/FBP.0b013e3282ee82e3
– ident: 2019081411491291000_341.3.681.39
  doi: 10.1111/j.1476-5381.1995.tb13303.x
– volume: 286
  start-page: 1115
  year: 1998
  ident: 2019081411491291000_341.3.681.20
  article-title: Role of 5-HT4 receptors in the mouse passive avoidance test
  publication-title: J Pharmcol Exp Ther
  contributor:
    fullname: Galeotti
– ident: 2019081411491291000_341.3.681.26
  doi: 10.1523/JNEUROSCI.3737-05c.2006
– ident: 2019081411491291000_341.3.681.12
  doi: 10.1046/j.1460-9568.2001.01361.x
– volume: 34
  start-page: 880
  year: 1988
  ident: 2019081411491291000_341.3.681.16
  article-title: A nonclassical 5-hyrdoxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system
  publication-title: Mol Pharmacol
  contributor:
    fullname: Dumuis
– ident: 2019081411491291000_341.3.681.25
– volume: 70
  start-page: 2252
  year: 1998
  ident: 2019081411491291000_341.3.681.6
  article-title: Cloning, expression, and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.1998.70062252.x
  contributor:
    fullname: Blondel
– volume: 14
  start-page: 2806
  year: 1995
  ident: 2019081411491291000_341.3.681.21
  article-title: The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants
  publication-title: EMBO J
  doi: 10.1002/j.1460-2075.1995.tb07280.x
  contributor:
    fullname: Gerald
– ident: 2019081411491291000_341.3.681.22
  doi: 10.1016/j.pharmthera.2009.03.002
– ident: 2019081411491291000_341.3.681.38
  doi: 10.1002/1099-081X(199912)20:9<429::AID-BDD209>3.0.CO;2-D
– ident: 2019081411491291000_341.3.681.2
  doi: 10.1016/0306-4522(91)90070-5
– ident: 2019081411491291000_341.3.681.35
  doi: 10.1254/jphs.FP0072230
– ident: 2019081411491291000_341.3.681.30
  doi: 10.1016/S0028-3908(96)00169-4
– ident: 2019081411491291000_341.3.681.3
  doi: 10.1046/j.1460-9568.2002.02005.x
– volume: 55
  start-page: 910
  year: 1999
  ident: 2019081411491291000_341.3.681.13
  article-title: Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain
  publication-title: Mol Pharmacol
  contributor:
    fullname: Claeysen
– ident: 2019081411491291000_341.3.681.5
  doi: 10.1101/lm.68004
– ident: 2019081411491291000_341.3.681.37
  doi: 10.1016/S0166-4328(01)00226-1
– ident: 2019081411491291000_341.3.681.19
  doi: 10.1016/S0028-3908(97)00055-5
– ident: 2019081411491291000_341.3.681.15
  doi: 10.1016/S0197-0186(98)00074-6
– ident: 2019081411491291000_341.3.681.41
  doi: 10.1038/mp.2008.28
– ident: 2019081411491291000_341.3.681.45
  doi: 10.1007/s002130050529
– ident: 2019081411491291000_341.3.681.1
  doi: 10.1007/BF02249415
– ident: 2019081411491291000_341.3.681.47
  doi: 10.1016/S0306-4522(97)00239-X
– volume: 296
  start-page: 676
  year: 2001
  ident: 2019081411491291000_341.3.681.32
  article-title: Evidence for involvement of central 5-HT4 receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: Matsumoto
– ident: 2019081411491291000_341.3.681.29
  doi: 10.1007/s00210-005-1068-0
– ident: 2019081411491291000_341.3.681.43
  doi: 10.1016/j.neuropharm.2011.02.026
– ident: 2019081411491291000_341.3.681.17
  doi: 10.1016/S0165-6147(00)89081-1
– ident: 2019081411491291000_341.3.681.11
  doi: 10.1016/j.bbr.2007.10.008
– ident: 2019081411491291000_341.3.681.44
  doi: 10.1111/j.1460-9568.2005.04560.x
– volume: 174
  start-page: 17
  year: 2004
  ident: 2019081411491291000_341.3.681.40
  article-title: Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-003-1683-8
  contributor:
    fullname: Roth
– ident: 2019081411491291000_341.3.681.23
  doi: 10.1124/jpet.107.130070
SSID ssj0014463
Score 2.3169308
SourceID crossref
SourceType Aggregation Database
StartPage 681
Title The 5-Hydroxytryptamine 4 Receptor Agonists Prucalopride and PRX-03140 Increase Acetylcholine and Histamine Levels in the Rat Prefrontal Cortex and the Power of Stimulated Hippocampal θ Oscillations
Volume 341
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtNAFB21ZcMG8RSUh-6CRkiuQ5IZ22GZVoGIZyiplF004xmjoDSxHFcQvow_YMc3ca_Hj0kpUmETWbZzFesezz0zOXMuY09Ft8NlXwR-xLn2RZBwH2mE8pErSHwBExFKmii-ex-OTsXraTDd2W05qqXzXLXj75fuK_mfrOI5zCvtkv2HzNZB8QQeY37xEzOMn1fOceCPNpq0KHm2SXN5RqxREBs0KU6nvcHnFXnjrr1xRp6zqzSb63KLwMnUJ1f5Do0RJE033iA2-WZBAyJFoZvIRcTGfEvqonUlizyROak3ErI_KJYfstx8q9WYY2q9VmyHyedn1B_MUKQ0xbqJo8_COzgeHhz1vQ9YfhcLZ8nwS_NYDlFOG3dtaxa11ZXA2UDWqCFt269as-8N2zVhz4r8aCtpM8u6Kr3CiJX-aGuZ_JP8iujzj-RaFpVjQIlwF0tIdVKJurY2L9j2FG1Tjvk9WlHpcLcocNF10M-dIT60LWZKthDaXmN_FqKeoEKEMx86bhOPLo11tyy_L5TiWiBZTM16YkYB6GhmA-yya2T4SD0i3nxs_i3DKT2vXfHx4UoLKwzw_MIvcNiXQ6MmN9mNMq0wsGC-xXbM8jZrjW2KN4cwcdJ5CC0YO8m_w37iZbgE8SCgQjxUiAcX8YC4gRrxUCEethBf3FQjHiziYb4ExBgg4qFBPFjEF9-gqwXiYZVAg3hwEA-_foCL9rvs9OVwcjzyy1YkftwNwtzvRUYjEY5DpLcKzyQ4MRC8L0OkCganVFJIcrUKOzrRcRAHsqPDXqCE6kahVi8Cfo_tLVdLc58BJzskrniktRRRFPWV0konYWBo_UPpB-xZlaJZah1nZn-Bw_7Vb33IrjfvwyO2l2fn5jHS6Vw9KbD0Gyae0cw
link.rule.ids 314,780,784,27924,27925
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+5-Hydroxytryptamine+4+Receptor+Agonists+Prucalopride+and+PRX-03140+Increase+Acetylcholine+and+Histamine+Levels+in+the+Rat+Prefrontal+Cortex+and+the+Power+of+Stimulated+Hippocampal+%CE%B8+Oscillations&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=Johnson%2C+David+E.&rft.au=Drummond%2C+Elena&rft.au=Grimwood%2C+Sarah&rft.au=Sawant-Basak%2C+Aarti&rft.date=2012-06-01&rft.issn=0022-3565&rft.eissn=1521-0103&rft.volume=341&rft.issue=3&rft.spage=681&rft.epage=691&rft_id=info:doi/10.1124%2Fjpet.112.192351&rft.externalDBID=n%2Fa&rft.externalDocID=10_1124_jpet_112_192351
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3565&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3565&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3565&client=summon